Atlas FDA

Axsym Total PSA & Architect Total PSA

FDA premarket approval P910007/S050 · decided 2017-03-28

Approval details

PMA number
P910007
Supplement
S050
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Axsym Total PSA & Architect Total PSA
Generic name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Applicant
Abbott Laboratories
Date received
2017-03-01
Decision date
2017-03-28
Days to decision
27 days
Decision code
OK30
Product code
MTF
Advisory committee
Immunology
Expedited review
No
Location
Abbott Park, IL
Statement
Change to convert the microparticle coating process from the automated microparticle processing system (AMPS) to the magnetic separation (MagSep) process.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Anti-HCV Next (K252424)Abbott Laboratories2026-04-28
ARCHITECT iGentamicin (K243500)Abbott Laboratories2025-07-09
Alinity i Rubella IgG (K243168)Abbott Laboratories2025-06-20
Alinity h-series System (K243283)Abbott Laboratories2025-02-20
Alinity i Toxo IgM (K233932)Abbott Laboratories2024-08-30
TBI (K232669)Abbott Laboratories2023-09-29
HAVAb IgG II (K222850)Abbott Laboratories2023-08-10
Alinity h-series System (K220031)Abbott Laboratories2023-08-04